Data as filed with the SEC, provided for information only — not investment advice.
Financial data temporarily unavailable. Try again in a few moments.
Who is buying and selling EXELON CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on EXC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on EXC and publish the result to your public profile.
Ask about EXELON CORP
Continue in Workspace — cited answers on EXC, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q/Aamend | 0000950159-02-000650 | Sep 30, 2002 | Nov 1, 2002 | Nov 1, 2002 22:26 UTC | EDGAR |
| 10-Q/Aamend | 0000950159-02-000646 | Jun 30, 2002 | Oct 31, 2002 | Oct 31, 2002 17:47 UTC | EDGAR |
| 10-Q/Aamend | 0000950159-02-000645 | Mar 31, 2002 | Oct 31, 2002 | Oct 31, 2002 17:46 UTC | EDGAR |
| 10-K/Aamend | 0000950159-02-000644 | Dec 31, 2001 | Oct 31, 2002 | Oct 31, 2002 17:44 UTC | EDGAR |
| 10-Q | 0000950159-00-000427 | Sep 30, 2000 | Nov 13, 2000 | Nov 13, 2000 05:00 UTC | EDGAR |
Direct links to SEC EDGAR. EXC has additional filings available on the SEC site.
6 numbers EXELON CORP later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q3 2021
Major restatementwas$1.4B
Revised down in a 10-Q.
Operating Income (Loss)·Q3 2021
Major restatementwas$1.9B
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2019
Major restatementwas$4B
Revised down in a 8-K.
Operating Income (Loss)·Q2 2021
Major restatementwas$366M
Revised up in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2020
Major restatementwas$2.3B
Revised down in a 10-K.
Revenues·Q1 2021
Major restatementwas$9.9B
Revised down in a 10-Q. Any P/S built on the original was 113.5% too low.
EXC is not the only one.
See every restatement we've found across the market — or get an alert the next time EXC revises a number.
Restatements are detected by comparing every vintage of a fact across all of EXELON CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows EXC's most significant revisions, and a figure absent from it has not been certified as unrevised.